Healthy Skepticism Library item: 11675
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Leibowitz AA, Sood N.
Market power and state costs of HIV/AIDS drugs.
Int J Health Care Finance Econ 2007 Mar; 7:(1):59-71
http://www.springerlink.com/content/8j873267p334v6v1/
Abstract:
We examine whether U.S. states can use their market power to reduce the costs of supplying prescription drugs to uninsured and underinsured persons with HIV through a public program, the AIDS Drug Assistance Program (ADAP). Among states that purchase drugs from manufacturers and distribute them directly to clients, those that purchase a greater volume pay lower average costs per prescription. Among states depending on retail pharmacies to distribute drugs and then claiming rebates from manufacturers, those that contract with smaller numbers of pharmacy networks have lower average costs. Average costs per prescription do not differ between the two purchase methods.
arleen@ucla.edu
Keywords:
Market power - State pharmaceutical costs - HIV/AIDS drugs - AIDS drug assistance program
Publication Types:
Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/economics
Anti-HIV Agents/supply & distribution*
Cost Control/methods
Drug Costs*
Drug Industry/economics*
Drug Utilization/economics
Government Programs
HIV Infections/drug therapy*
HIV Infections/economics
Humans
Marketing/economics*
Medical Assistance/statistics & numerical data*
Medically Uninsured*
Models, Econometric
Multivariate Analysis
Prescription Fees/trends
Rate Setting and Review/methods
State Government
United States
Substances:
Anti-HIV Agents
